Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials
View Full Paper
Ask AI
Bookmark
Share
No abstract yet
We only have this paper's title and publication details.